BlinkLab is trading 5.69% down at A$0.58; no clear company-specific catalyst has been identified.
- The latest identified company updates were investor-presentation announcements dated October 9 and October 13, not a new announcement on October 15.
- Inflation and interest-rate concerns were weighing on risk appetite, but the supplied context does not establish a direct link to the decline. Healthcare was up, and no trading-volume information was available.